Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose alfentanil effect on remimazolam ED50/ED95 for pediatric anesthesia induction sedation
ChiCTR2400090045Phase 4Recruiting
- Sponsor
- Weifang People's Hospital
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam and alfentanil in None (2 arms), sponsored by Weifang People's Hospital. Primary endpoints: ED50 of remimazolam and ED95 of remimazolam. Started Sep 2024; status: recruiting.
02
Drugs
remimazolamalfentanil
Beyond the preview
Go deeper on ChiCTR2400090045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400090045.